Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. STZ

Go back to Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range

Raymond James Downgrades Abbott Labs (ABT) to Market Perform

October 18, 2012 7:51 AM EDT

Raymond James downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.

Shares of Abbott Labs closed at $69.04 yesterday, with a 52 week range of $51.53-$72.47.... More

Abbott Laboratories (ABT) Tops Q3 EPS by 2c; Narrows FY12 EPS Outlook

October 17, 2012 7:45 AM EDT

Abbott Laboratories (NYSE: ABT) reported Q3 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $9.77 billion versus the consensus estimate of $9.93 billion.

Abbott Laboratories sees FY2012 EPS of $5.06-5.08, versus prior guidance of $5.00-5.10 and the consensus of $5.06.... More